Sunday 16 December 2018
Home      All news      Contact us      Philipino
Channel News Asia - 3 month ago

Viking shares soar as liver disease drug succeeds in mid-stage study

REUTERS: Viking Therapeutics Inc s shares more than doubled on Tuesday after its experimental liver disease treatment met the goals of a mid-stage trial by lowering cholesterol and liver fat levels in patients. The study tested Viking s VK2809 against a placebo in patients with non-alcoholic fatty ...

Related news

Latest News
Hashtags:   

Viking

 | 

shares

 | 

liver

 | 

disease

 | 

succeeds

 | 

stage

 | 

study

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources